| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Article |
From the Surgical Research Laboratory,*
Division of
Plastic Surgery,
and Department of
Surgery,
Children’s Hospital, and the
Department of Pathology,
Beth Israel
Deaconness Medical Center, Harvard Medical School,
Boston, Massachusetts
Infantile hemangiomas are endothelial tumors that grow rapidly in the first year of life and regress slowly during early childhood. Although hemangiomas are well-known vascular lesions, little is known about the mechanisms that cause the excessive endothelial cell proliferation in these most common tumors of infancy. To investigate the molecular basis of hemangioma, we isolated endothelial cells from several proliferative-phase lesions and showed that these cells are clonal and exhibit abnormal properties in vitro (E. Boye, Y. Yu, G. Paranya, J. B. Mulliken, B. R. Olsen, J. Bischoff: Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 2001, 107:745–752). Here, we analyzed mRNA expression patterns of genes required for angiogenesis, including members of the vascular endothelial growth factor (VEGF)/VEGF receptor family and the angiopoietin/Tie family, in hemangioma-derived and normal endothelial cells. KDR, Flt-1, Tie1, Tie2, and angiopoietin-2 (Ang2) were strongly expressed in cultured hemangioma-derived endothelial cells and in hemangioma tissue. In contrast, there was little expression of angiopoietin-1 (Ang1) or VEGF. We found Tie2 mRNA and protein up-regulated with a concomitant increase in cellular responsiveness to Ang1 in most hemangioma-derived endothelial cells. Ang2 mRNA was down-regulated in response to serum in hemangioma-derived endothelial cells, but not in normal endothelial cells, suggesting altered regulation. These findings implicate Tie2 and its ligands Ang1 and Ang2 in the pathogenesis of hemangioma.
This article has been cited by other articles:
 |
|
 |
|
  L. Bezuidenhout, M. Bracher, G. Davison, P. Zilla, and N. Davies Ang-2 and PDGF-BB cooperatively stimulate human peripheral blood monocyte fibrinolysis J. Leukoc. Biol., June 1, 2007; 81(6): 1496 - 1503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Macdonald, P. Progias, B. Ciani, S. Patel, U. Mayer, M. O. Steinmetz, and R. A. Kammerer Structure of the Extracellular Domain of Tie Receptor Tyrosine Kinases and Localization of the Angiopoietin-binding Epitope J. Biol. Chem., September 22, 2006; 281(38): 28408 - 28414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yu, J. Fuhr, E. Boye, S. Gyorffy, S. Soker, A. Atala, J. B. Mulliken, and J. Bischoff Mesenchymal Stem Cells and Adipogenesis in Hemangioma Involution Stem Cells, June 1, 2006; 24(6): 1605 - 1612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Phelps, D. L. Updike, E. C. Bullen, P. Grammas, and E. W. Howard Transcriptional and posttranscriptional regulation of angiopoietin-2 expression mediated by IGF and PDGF in vascular smooth muscle cells Am J Physiol Cell Physiol, February 1, 2006; 290(2): C352 - C361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Smolinski and A. C. Yan Hemangiomas of Infancy: Clinical and Biological Characteristics Clinical Pediatrics, November 1, 2005; 44(9): 747 - 766. [Abstract] [PDF]
|
|
|
|
 |
|
 T. L. Phung, M. Hochman, and M. C. Mihm Current Knowledge of the Pathogenesis of Infantile Hemangiomas Arch Facial Plast Surg, September 1, 2005; 7(5): 319 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yu, A. F. Flint, J. B. Mulliken, J. K. Wu, and J. Bischoff Endothelial progenitor cells in infantile hemangioma Blood, February 15, 2004; 103(4): 1373 - 1375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Ritter, M. I. Dorrell, J. Edmonds, S. F. Friedlander, and M. Friedlander From the Cover: Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis PNAS, May 28, 2002; 99(11): 7455 - 7460. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
